By G HossainPosted on August 27, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs A future expansion of Rasonque into first-line pancreatic ductal adenocarcinoma could set Revolution Medicines up to hit $2.3 billion in sales by 2028, according to Truist Securities. RevMed could become ‘next oncology titan’ with Rasonque nod Post navigation Nearly 1/4 dealing with long-term unemployment call it quits on biopharma job searchesGenerate Bio drops as data accidentally leaked ahead of European conference